Mike Rogers graduated from the University of Sheffield, UK, with a first class honours in Biochemistry in 1989 and earned a PhD in bone pharmacology in 1994. They served as a postdoctoral fellow and later held positions at the University of Aberdeen, becoming a Professor of Musculoskeletal Pharmacology and leading a significant Musculoskeletal Research Programme. In 2012, Mike relocated to the Garvan Institute of Medical Research to establish the Bone Therapeutics Group and currently co-leads a strategic research program focused on skeletal disease. Their past research has notably advanced the understanding of bisphosphonates and made important contributions to bone cell biology and human bone diseases.
This person is not in the org chart
This person is not in any teams
This person is not in any offices